http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-41285-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3b284e66f59ceaa4a2bc78b38516a5e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-664 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 |
| filingDate | 1992-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8965ffc5c93176e1c4c499649b1c5fba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_508d6c21e799685e568fcf1b437300be |
| publicationDate | 2001-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-41285-C2 |
| titleOfInvention | CREATINE PHOSPHATE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR TREATMENT OF TUMORS AND PHARMACEUTICAL COMPOSITION WITH ANTUCTUMINAL |
| abstract | The present invention relates to the use of compounds having a phosphamide bond or an enol phosphate bond for the preparation of pharmaceutical preparations for the treatment of tumors. A pharmaceutical composition for inhibiting or reducing tumor growth in mammals contains an active principle and a pharmaceutically acceptable carrier. The active principle is selected from creatine phosphate and its pharmaceutically acceptable salts in an amount of 0.1 to 50 g per composition. |
| priorityDate | 1991-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID587 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526951 |
Total number of triples: 18.